Lallemand to acquire Nova Microbial Technologies

Deal will expand prospects for innovation

Lallemand Animal Nutrition will acquire Nova Microbial Technologies ─ forwarding Lallemand’s mission to provide natural microbial products and services for optimized animal performance and well-being.

“This acquisition creates exciting opportunities for Lallemand Animal Nutrition and Nova customers and, more importantly, the livestock industries we serve,” said Jeff Ast, commercial director, Lallemand Animal Nutrition, North America. “Our common values ─ including the commitment to quality and research, as well as strong customer relationships ─ make this a logical step in strengthening our ability to deliver advanced microbial solutions.”

Alan Larsen, president, Nova Microbial Technologies, is looking forward to offering a broader portfolio to help animal agriculture produce the safe, wholesome end-products consumers are demanding.

The combined portfolios will allow for potential synergies as well as prospects for innovation in the United States and globally.

Lallemand Animal Nutrition develops, manufactures and markets high-value yeast and bacteria products including probiotics, silage inoculants and yeast derivatives. Using sound science, proven results and knowledge from experience, Lallemand applies the right strains for the right applications to have the greatest impact and return on investment for customers.

Nova Microbial Technologies markets direct-fed microbials, Yucca schidigera whole plant powder extract, IgY technologies, silage inoculants, and specialty products produced with commitment to integrity and product quality.